Cutaneous lymphomas;Linfomas cutaneos

Medicina Cutanea Ibero-Latino-Americana

Volumn 26, Issue 3, 1998, Pages 113-136

  Marti Laborda, Rosa M ^b   Estrach Panella, Teresa ^b  

^a UNIVERSITY OF LLEIDA   (Spain)

^b NONE

Author keywords

Classification; Cutaneous lymphomas; Diagnosis; Treatment

Indexed keywords

ALPHA INTERFERON; CD20 ANTIGEN; CD30 ANTIGEN; CYCLOSPORIN; KI 67 ANTIGEN; METHOXSALEN; RECOMBINANT INTERLEUKIN 2;

CANCER STAGING; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; MYCOSIS FUNGOIDES; PAPULOSIS; REVIEW; SEZARY SYNDROME; SKIN LYMPHOMA; SYNDROME DELINEATION;

EID: 0032417414     PISSN: 02105187     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. WILLEMZE, R.; KERL, H.; STERRY,W.; BERTI, E. CERRONI, L.; CHIMENTI, S.; DIAZ-PÉREZ, J.L.; GEERTS, M.L.; GOOS, M.; KNOBLER, R.; RALFKIAER, E.; SANTUCCI, M.; SMITH, N.; WECHSLER, J.; VAN VLOTEN, W.A.; MEIJER, C.J.L.M.; EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer. Blood 1997; 90: 354-371
2. MARTI, R.M.; ESTRACH, T.; Linfomas cutáneos (1): Linfomas T. Piel 1990; 5: 473-482
3. ALIBERT, J.L.; Descriptions de maladies de la peau observées a l'Hôpital de St. Louis et exposition des meilleurs méthodes suivies pour leur traitement. Paris, Barrois L'Ainé et Fils, 1806
4. HARRIS, N.L.; JAFFE, E.S. STEIN, H.; BANKS, P.M., CHAN, J.K.C.; CLEARY, M.L., DELSON, G.; DE WOLFPEETERS, C.; FELINI, B.; GATTER, K.C.; GROGEN, T.M.; ISAACSON, P.G.; KNOWLES, D.M.; MASON, D.Y.; MULLER-HERMELINK, H.K.; PILERI, S.A.; PIRIS, M.A.; RALFKIAER, E.; WARNKE, R.A.; A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392
5. WILLEMZE, R.; BELJAARDS, R.C.; Spectrum of primary cutaneous CD30 (Ki-l)positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment. J Am Acad Dermatol 1993; 28: 973-980)
6. WILLEMZE, R.; New concepts in the classification of cutaneous lymphomas. Arch Dermatol 1995; 1: 1077-1080
7. DECOTEAU, J.F.; BUTMARC, J.R.; KINNEY M.C.; KADIN, M.E.; The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-Cell lymphoma of nodal origin. Blood 1996; 87: 3437-3441
8. WEISS, L.M.; WOOD, G.S.; TRELA, M.; WARNKE, R.A.; SKLAR, J.; Clonal T-cell population in lymphomatoid papulosis: evidence of a lymphoproliferative origin for a clinically benign disease. N Eng J Med 1986; 315: 475-479
9. WOOD GS, CROOKG CF, ULUER AZ. Lymphomatoid papulosis and associated cutaneous lymphoproliferative disorders exhibit a common clonal origin. J Invest Dermatol 1995; 105: 51-55
10. CHOTT, A.; VONDERHEID, E.C.; OLBRICHT, S.; MIAO, N.N.; BALK, S.P.; KADIN, M.E.; The same dominant T-cell done is present in multiple skin lesions and associated Tcell lymphomas of patients with lymphomatoid papulosis. J Invest Dermatol 1996; 106: 696-700
11. LE BOIT, P.E.; ZACKHEIM, H.; WHITE, C.R.J.R.; Granulomatous variants of cutaneous T-cell lymphoma: the histopathology of granulomatous mycosis fungoides and granulomatous slack skin. Am J Surg Pathol 1988; 12: 83-95
12. LE BOIT, P.E.; Granulomatous slack skin. Dermatol Clin 1994; 12: 375-389
13. NOTO, G.; PRAVATA, G.; MICELI, S.; ARICO, M.; Granulomatous slack skin: report of a case associated with Hodgkin's disease and a review of the literature. Br J Dermatol 1994; 131: 275-279
14. MOULY, F.; BACCARD, M.; CAYUELA, J.M.; JANSSEN, E.; VEROLA, O.; FLAGEUL, B.; MOREL, P.; Cutaneous T-cell lymphoma associated with granulomatous slack skin. Dermatology 1996; 192: 288-290
15. PUIG, S.; IRANZO, P.; PALOU, J.; MARTÍ, R.; ESTRACH, T.; MASCARÓ, J.M.; Lymphoproliferative nature of granulomatous slack skin: clonal rearrangement of the T-cell receptor beta-gene. Arch Dermatol 1992; 138: 562-563
16. LE BOIT, P.E.; BECKSTEAD, J.H.; BOND, B.; EFSTEIN, W.L.; FRIEDEN, I.J.; PARSLOW, T.G.; Granulomatous slack skin: clonal rearrangement of the T-cell receptor beta gene is evidence for the lymphoproliferative nature of a cutaneous elastolytic disorder. J Invest Dermatol 1987; 89: 183-186
17. FRIEDMANN, D.; WECHSLER, J.; DELFAU M.H.; ESTÉVE, E.; FARCET, J.P.; DE MURET, A.; PARNEIXSPAKE, A.; VAILLANT, L.; REVUZ, J.; BAGOT, M.; Primary cutaneous pleomorphic small T-cell lymphcma. Review of 11 cases. Arch Dermatol 1995; 131: 1009-1015
18. BERTI, E.; ALESSI, E.; CAPUTO, R.; Reticulohisticcytoma of the dorsum (Crosti's disease) and other B-cell lymphomas. Sem Diagn Pathol 1991; 2: 82-90
19. SANTUCCI, M.; PIMPINELLI, N.; ARGANINI, L.; Primary cutaneous B-cell lymphoma: unique type of low-grade lymphoma. Clinicopathologic and immunologic study of 83 cases. Cancer 1991; 67: 2311-2326
20. SLATER, D.N.; MALT and SALT: the clue to cutaneous B-cell lymphoproliferative disease. Br J Dermatol 1934; 131: 557-561
21. WILLEMZE, R.; RIJLAARSDAM, J.U.; MEIJER, C.J.L.M.; Are most primary cutaneous BCell lymphomas 'marginal cell lymphomas'? Br J Dermatol 1995; 133: 950-954
22. SLATER, D.; Are most primary cutaneous B-cell lymphomas 'marginal cell lymphomas'?: Reply. Br J Dermatol 1995; 133: 950-954
23. ASHTON-KEY, M.; JESSUP, E.; ISAACSON, P.G.; Immunoglobulin light chain staining in paraffin-embedded tissue using a heat mediated epitope retrieval method. Histopathology 1996 29: 525-531
24. VERMEER, M.H.; GEELEN, F.A.M.J.; VAN HASELEN, C.W.; VAN VOORST VADER, P.C.; GEERST, M.L.; VAN VLOTEN, W.A.; WILLEMZE, R.; Primary cutaneous large B-cell lymphomas of the legs. Arch Dermatol 1996; 132: 1304-1308
25. SÁNCHEZ, J.L.; ACKERMAN, A.B.; The patch stage of mycosis fungoides. Criteria for histologic diagnosis. Am J Dermatopathol 1979; 1: 5-25
26. LE BOIT, P.E.; Cutaneous lymphomas and their histopathologic imitators. Sem Dermatol 1986; 5: 322-333
27. OLERUD, J.E.; KULIN, P.A.; CHEW, D.E.; CARISEN, R.A.; HAMMAR, S.P.; WEIR, T.W.; PATTERSON, S.D.; BOLEN, J.W.; KAIDIN, M.D.; BARKER, E.; KIDD, P.G.; MCNUTT, M.A.; PIEPKORN, M.W.; Cutaneous T-cell lymphoma. Evaluation of pretreatment skin biopsy specimens by a panel of parhologists. Arch Dermatol 1992; 128: 501-507
28. SMITH, N.P.; Histologic criteria for early diagnosis of cutaneous T-cell lymphoma. Dermatol Clin 1994; 12: 315-322
29. SMOLLER, B.R.; BISHOP, K.; GLUSAC, E.; KIM, Y.H.; HENDRICKSON, M.; Reassessment of histologic parameters in the diagnosis of mycosis fungoides. Am J Surg Pathol 1995; 19: 1423-1430
30. BUECHNER, S.A.; WINKELMANN, R.K.; Sézary syndrome: a clinicopathologic study of 39 cases. Arch Dermatol 1933; 119: 979-986
31. SENTIS, H.J.; WILLEMZE, R.; SCHEFFER, E.; Histopathologic studies in Sézary syndrome and erythrodermic mycosis fungoides: a comparison with benign forms erythroderma. J Am Acad Dermatol 1986; 15: 1217-1226
32. WIESELTHIER, J.S.; KOH, H.K.; Sézary syndrome: Diagnosis, prognosis and critical review of treatment options. J Am Acad Dermatol 1990; 22: 381-401
33. MARTÍ, R.M.; ESTRACH, T.; REVERTER, J.C.; MASCARÓ, J.M.; Prognostic clinicopathologic factors in cutaneous T-cell lymphoma. Arch Dermatol 1991; 127: 1511-1516
34. KOHLER, S.; KIM, Y.H.; SMOLLER, B.R.; Histologic criteria for the diagnosis of erythrodermic mycosis fungoides and Sézary syndrome: a critical reappraisal. J Cut Pathol 1997; 24: 292-297
35. TROTTER, M.J.; WHITTAKER, S.J.; Orchard GE et al. Cutaneous histopathology of Sézary syndrome: a study of 41 cases with a proven circulating T-cell clone. J Cut Pathol 1997; 24: 286-291
36. RALFKIAER, E.; Immunohistological markers forthe diagnosis of cutaneous lymphomas. Sem Diagn Pathol 1992; 8: 62-72
37. PERKINS, S.L.; KJELDSBERG, C.R.; Immunophenoyping of lymphomas and leukemias in paraffin-embedded tissues. Hematopathology 1993; 99: 362-373
38. RALFKIAER, E.; WOLLF-SNEEDORFF A.; THOMSEN, K.; VEJLSGAARD, G.L.; Immunophenotypic studies in cutaneous T-cell lymphomas: Clinical implications. Br J Dermatol 1993; 129: 655-659
39. SLATER, D.N.; Review of investigative techniques for cutaneous lymphomas. Sem Dermatol 1994; 13: 166-171
40. RITTER, J.H.; ADESOKAN, N.P.; FITZGIBBON, J.F.; WICK, M.R.; Paraffin section immunohistochemistry as an adjunt to morphologic analysis in the diagnosis of cutaneous lymphoid infiltratres. J Cut Pathol 1994; 21: 481-493
41. CERRONI, L.; KERL, H.; The use of monoclonal antibodies on paraffin sections in the diagnosis of cutaneous lymphoproliferative disorders. Dermatol Clin 1994; 12: 219-229
42. ESTRACH, T.; MARTÍ, R.M.; FORMIGON, M.; PALOU, J.; Utility of immunohistochemistry in the diagnosis of cutaneous lymphoma. Skin Cancer 1995; 10: 231-240
43. SHI, S.H.; COTE, R.J.; TAYLOR, C.R.; Antigen retrival immunohistochemistry: past, present and future. J Histochem Cytochem 45: 327-343, 1997
44. NOVELLI, M.; FIERRO, M.T.; QUAGLINO, P.; LISA, F.; DOVEIL, G.G.; BERNENGO, M.G.; CD26 (DPP-IV): A usefull marker in Sézary syndrome. J Invest Dermatol 1994; 103 :448
45. WEISS, L.M.; HU, E.; WOOD, G.S.; MOULDS, C.; CLEARY, M.; WARNKE, R.; SKLAR, J.; Clonal rearrangements of T-cell receptor genes in mycosis fungoides and dermatopathic lymphadenopathy. N Engl J Med 1985; 313: 539-544
46. TERHUNE, M.H.; COOPER, K.D.; Gene rearrangements and T-cell lymphomas. Arch Dermatol 1993; 129: 1484-1490
47. WEINBERG, J.M.; ROOK, A.H.; LESSIN, S.R.; Molecular diagnosis of lymphocytic infiltrates of the skin. Arch Dermatol 1993; 129: 1491-1500
48. TILLMAN, D.M.; Gene rearrangement studies in cutaneous lymphoma. Skin Cancer 1993; 8: 285-293
49. MIELKE, V.; STAIB, G.; BOEHNCKE, W.H.; DULLER, B.; STERRY W.; Clonal disease in early cutaneous T-cell lymphoma. Dermatol Clin 1994; 12: 351-360
50. WOOD, G.; HAEFFNER, A.; DUMMER, R.; CROOKS, C.F.; Molecular biology techniques for the diagnosis of cutaneous T-cell lymphoma. Dermatol Clin 1994; 12: 231-241
51. VOLKENANDT, M.; WIENECKE, R.; TIEMANN, M.; Detection of monoclonal cell populations by polimerase chain reaction technology. Dermatol Clin 1994; 12: 341-349
52. BACHELEZ, H.; BIOUL, L.; FLAGEUL, B.; BACCARD, M.; MOULONGUET-MICHAU, I.; VEROLA, O.; MOREL, P.; DUBERTRET, L.; SIGAUX, F.; Detection of clonal T-cell receptor gamma gene rearrangements with the use of the polymerase chain reaction in cutaneous lesions of mycosis fungoides and Sézary syndrome. Arch Dermatol 1995; 131: 1027-1031
53. CURCÓ, N.; SERVITJE, O.; LLUCIA, M.; BERTRAN, J.; LIMON, A.; CARMONA, M.; ROMAGOSA, V.; PEYRI, J.; Genotypic analysis of cutaneous T-cell lymphoma: a comparative study of Southern blot analysis with polymerase chain reaction amplification of the T-cell receptor-gamma gene. Br J Dermatol 1997; 137: 673-679
54. DOMMANN, S.N.W.; DOMMANN-SCHERRER, C.C.; DOURS-ZIMMERMANN, M.T.; ZIMMERMANN, D.R.; KURAL-SERBES, B.; BURG, G.; Clonal disease in extracutaneous compartments in cutaneous T-cell lymphomas and pseudolymphomas. A comparative study between cutaneous T-cell lymphomas and pseudolymphomas. Arch Dermatol Res 1996; 288: 163-167
55. MUCHE, J.M.; LUKOWSKY, A.; ASADULLAH, K.; GELLRICH, S.; STERRY, W.; Demonstration of frequent occurrence of clonal T cells in the peripheral blood of patients with primary cutaneous T-cell lymphoma. Blood 1997; 90: 1636-1642
56. FOSS, F.M.; SAUSVILLE, E.A.; Prognosis and staging of cutaneous T-cell lymphomas. Hematol/Oncol Clin North Am 1995; 9: 1011-1019
57. TORO, J.R.; STOLL, P.C.; STOMPER, P.C.; OSEROFFAR. Prognostic factors and evaluation of mycosis fungoides and Sézary syndrome. J Am Acad Dermatol 1997; 37: 58-67
58. BUNN, A.P.; LAMBERG, S.I.; Report of the Comnitee on staging and classification of cutaneous T-cell lymphomas. Cancer Treat Rep 1979; 63: 725-728
59. SAUSVILLE, E.A.; EDDY; J.L.; MAKUH, R.W.; FISHMANN, A.B.; SCHECHTER, G.P.; MATTHEWS, M.; GLATSTEIN, E.; IHDE, D.C.; KAYE, E.; VEACH, S.R.; PHELPS, R.; O'CONNOR, T.; TREPEL, J.B.; COTELINGAM, J.D.; GAZDAR, A.F.; MINNA, J.D.; BUNN, J.R.P.A.; Histopathological diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three prognostic groups. Ann Int Med 1988; 109: 372-382
60. MARTÍ, R.M.; ESTRACH, T.; REVERTER, J.C.; CAMPO, E.; BRUGUES, R.; BRUGUERA, M.; MASCARÓ, J.M.; Utility of bone marrow and liver biopsies for staging cutaneous T-cell lymphoma. Int J Derrnatol 1996; 35: 450-454
61. KIM, Y.H.; BISHOP, K.; VARGHESE, A.; HOPPE, R.T.; Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome. Arch Dermatol 1995; 181: 1003-1008
62. YAMAMURA, T.; AOZASA, K.; SANO, S.; The cutaneous lymphomas with convoluted nucleus, J Am Acad Dermatol 1984; 10: 796-803
63. VONDERHEID, E.C.; TAN, D.W.; JOHNSON, W.C.; VAN SCOTT, E.J.; WALLNER, P.E.; Prognostic significance of cytomorphology in cutaneous T-cell lymphoma. Cancer 1981; 47: 119-125
64. VONDERHEID, E.C.; TAN, E.; SABEL, E.L.; SCHWAB, E.; MICAILY B.; JEGASOTHY, B.V.; Clinical implications of immunologic phenotyping in cutaneous T-cell lymphoma. J Am Acad Dermatol 1987; 17: 40-52
65. WOOD, G.S.; Lymphocyte activation in cutaneous T-cell lymphoma. J Invest Dermatol 1995; 105: 105s-109s
66. WASIK, M.A.; VONDERHEID, E.G.; BIGLER, R.D.; MARTÍ, R.; LESSIN, S.R.; POLANSKY, M.; KADIN, M.E.; Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Arch Dermatol 1996; 132: 42-47
67. JONES, S.E.; Enigma of therapy for cutaneous lymphoma. J Natl Cancer Inst 1990; 82: 169-170
68. KUZEL, T.M.; SPRINGER, E.; ROEGNIGK, H.H.; ROSEN, S.T.; Mycosis fungoides: Time to define the best therapy. J Natl Cancer Inst 1990; 82: 183-185
69. KOH, H.K.; JACOBSON, J.O.; Is cutaneous T-cell lymphoma curable? Arch Dermatol 1995; 131: 1081-1082
70. BUNN, P.A.; Rational therapy for cutaneous T-cell lymphomas in the 1990s. Fact or fancy? Arch Dermatol 1995; 131: 603-605
71. KAYE, F.J.; BUNN, P.A.J.R.; STEINBERG, S.M.; STOCKER, J.L.; IHDE, D.C.; FISCHMANN, A.B.; GLATSTElN, E.J.; SCHECHTER, G.; PHELPS, R.M.; FOSS, F.; PARLETTE, H.L.; ANDERSON, M.J.; SAUSVILLE, E.A.; A randomized trial comparing combination electron-beam therapy and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 1989; 321: 1734-1790
72. ESTRACH, T.; MARTÍ, R.M.; Linfomas cutáneos (III): tratamiento. Piel 1990; 5: 513-518
73. ZACKHEIM, H.S.; Treatment of cutaneous T-cell lymphoma. Sem Dermatol 1994; 13: 207-215
74. DUVIC, M.; HESTER, J.P.; LEMAK, N.A.; Photopheresis therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 1996; 35: 573-579
75. ZIC, J.A.; STRICKLIN, G.P.; GREER, J.P.; KINNEY, M.C.; SHYR, Y.; WILSON, D.C.; KING, L.E.; Long term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy. J Am Acad Dermatol 1996; 35: 935-945
76. GOTTLIEB, S.L.; JONAHTAN, T.W.; FOX, F.E.; DENARDO, B.J.; MACEY, W.H.; BROMLEY, P.G.; LESSIN, S.R.; ROOK, A.H.; Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10 year experience at a single institution. J Am Acad Dermatol 1996; 35: 946-957
77. BUNN, P.A.; HOFFMAN, S.F.; NORRIS, D.; GOLITZ, L.E.; AELING, J.L.; Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome). Ann Intern Med 1994; 121: 592-602
78. SCHAPPEL, D.L.; ALPER, J.C.; MCDONALD, C.J.; Treatment of advanced mycosis fungoides and Sézary syndrome with continuous infusions of methotrexate followed by fluouracil and leucovorin rescue. Arch Dermatol 1995; 131: 307-313
79. HALBERG, F.E.; FU, K.K.; WEAVER, K.A.; ZACKHEIM, H.S.; EPSTEIN, E.H.; WINTROUB, B.U.; Combined total body X irradiation and total skin electron beam radiotherapy with an improved technique for mycosis fungoides. Int J Radiation Oncolology Biol Phys 1989, 17: 427-432
80. BIGLER, R.D.; CRILLEY, P.; MICAILY, B., BRADY, L.W.; TOPOLSKY, D.; BULOVA, S.; VONDERHEID, E.C.; BRODSKY, I.; Autologous bone marrow transplantation for advanced stage mycosis fungoides. Bone Marrow Transplantation 1991; 7: 133-137.
81. O., SERVITJE; C., FERRÁ.; L., PÉTRIZ.; T., ESTRACH.; R.M., MARTÍ.; A., LIMÓN.; A , FONT.; A., GRAÑENA.; J., PEYRI.; Transplante de precursores hematopoyéticos en un caso de micosis fungoides. XIV Reunión Clínica Internacional de Barcelona. 24-25 de octubre de 1997
82. MARTÍ, R.M.; CASANOVA, J.M.; ESTRACH, T.; Linfomas cutáneos y citocinas. Piel 1997; 12: 348-356